These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10392866)

  • 1. Comparison of sotalol versus quinidine for maintenance of normal sinus rhythm in patients with chronic atrial fibrillation.
    Southworth MR; Zarembski D; Viana M; Bauman J
    Am J Cardiol; 1999 Jun; 83(12):1629-32. PubMed ID: 10392866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of atrial fibrillation recurrence during therapy with sotalol or quinidine. Researchers of +SOCESP].
    Veloso HH; de Paola AA
    Arq Bras Cardiol; 1998 Jan; 70(1):43-9. PubMed ID: 9629687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of sotalol versus quinidine for the maintenance of sinus rhythm after conversion of atrial fibrillation. SOCESP Investigators. The Cardiology Society of São Paulo.
    de Paola AA; Veloso HH
    Am J Cardiol; 1999 Nov; 84(9):1033-7. PubMed ID: 10569659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is oral sotalol effective in converting atrial fibrillation to sinus rhythm?
    Ferreira E; Sunderji R; Gin K
    Pharmacotherapy; 1997; 17(6):1233-7. PubMed ID: 9399605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
    Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP
    Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.
    Juul-Möller S; Edvardsson N; Rehnqvist-Ahlberg N
    Circulation; 1990 Dec; 82(6):1932-9. PubMed ID: 2242519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Allessie MA
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):178-93. PubMed ID: 10090222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].
    Fetsch T; Burschel G; Breithardt G; Engberding R; Koch HP; Lukl J; Trappe HJ; Treese N
    Z Kardiol; 1999 Mar; 88(3):195-207. PubMed ID: 10355070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
    Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
    Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C; Mouly S; Longas-Tejero MA; Bergmann JF
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005049. PubMed ID: 17943835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison].
    Kalusche D; Stockinger J; Betz P; Roskamm H
    Z Kardiol; 1994; 83 Suppl 5():109-16. PubMed ID: 7846939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial).
    Halinen MO; Huttunen M; Paakkinen S; Tarssanen L
    Am J Cardiol; 1995 Sep; 76(7):495-8. PubMed ID: 7653451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
    Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C
    Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone versus sotalol for atrial fibrillation.
    Singh BN; Singh SN; Reda DJ; Tang XC; Lopez B; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Raisch DW; Ezekowitz MD;
    N Engl J Med; 2005 May; 352(18):1861-72. PubMed ID: 15872201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.
    Kerin NZ; Faitel K; Naini M
    Arch Intern Med; 1996 Jan; 156(1):49-53. PubMed ID: 8526696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A
    Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.